Effects of the MAML2 genetic variants in glioma susceptibility and prognosis

Background: Abnormal expression of the mastermind-like transcriptional co-activator 2 (MAML2) gene is oncogenic in several human cancers, including glioma. However, the relevance of MAML2 variants with glioma remains unknown. We aimed to investigate the role of MAML2 polymorphisms in glioma risk and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming, Zhao, Yonglin, Zhao, Junjie, Huang, Tingqin, Guo, Xiaoye, Ma, Xudong, Wu, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822528/
https://www.ncbi.nlm.nih.gov/pubmed/31652449
http://dx.doi.org/10.1042/BSR20192091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822528/
https://www.ncbi.nlm.nih.gov/pubmed/31652449
http://dx.doi.org/10.1042/BSR20192091

Ejemplares similares